Literature DB >> 1910680

MHC class-I transgenic mice.

B Arnold1, G J Hämmerling.   

Abstract

The introduction of cloned genes into the germline of mice has been proven to be a powerful tool to investigate the role of the respective gene products within the immune system. Here we summarize the transgenic mouse models that have been established with major histocompatibility complex (MHC) class-I genes. Foreign class-I alleles can be expressed in transgenic mice according to their normal expression patterns as authentic self molecules and can function in T-cell responses in the same way as endogenous class-I molecules. Since this is also true for most of the introduced human HLA class-I alleles, there is great interest in establishing mouse models for HLA-linked diseases. A new field of experimental approaches concerning self-tolerance has been opened by tissue specific expression of MHC antigens under specific promoters. Besides negative selection in the thymus, peripheral mechanisms could be identified that induce and maintain self-tolerance.

Entities:  

Mesh:

Year:  1991        PMID: 1910680     DOI: 10.1146/annurev.iy.09.040191.001501

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  7 in total

Review 1.  Dominant regulation: a common mechanism of monoclonal antibody induced tolerance?

Authors:  K Honey; S P Cobbold; H Waldmann
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Alternative splicing of class Ib major histocompatibility complex transcripts in vivo leads to the expression of soluble Qa-2 molecules in murine blood.

Authors:  P Tabaczewski; H Shirwan; K Lewis; I Stroynowski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-01       Impact factor: 11.205

3.  Induction in transgenic mice of HLA-A2.1-restricted cytotoxic T cells specific for a peptide sequence from a mutated p21ras protein.

Authors:  P Escobar; Z Yu; A Terskikh; N Holmes; G Corradin; J P Mach; F Healy
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

4.  FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.

Authors:  A Azoulay; M Brahic; J F Bureau
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

5.  Mamu-A01/K(b) transgenic and MHC Class I knockout mice as a tool for HIV vaccine development.

Authors:  Jinliang Li; Tumul Srivastava; Ravindra Rawal; Edwin Manuel; Donna Isbell; Walter Tsark; Corinna La Rosa; Zhongde Wang; Zhongqi Li; Peter A Barry; Katharine D Hagen; Jeffrey Longmate; Don J Diamond
Journal:  Virology       Date:  2009-02-27       Impact factor: 3.616

6.  Serum antibodies from patients with ankylosing spondylitis and Reiter's syndrome are reactive with HLA-B27 cells transfected with the Mycobacterium tuberculosis hsp60 gene.

Authors:  H Kellner; J Wen; J Wang; R B Raybourne; K M Williams; D T Yu
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice.

Authors:  S Pascolo; N Bervas; J M Ure; A G Smith; F A Lemonnier; B Pérarnau
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.